TNNT2 and cerebral cavernous malformation: To date, no study evaluating the prognostic value of hs-cTnT, Gal-3, NGAL, sST2, and Cys-c in CCM has been reported, and our group recently reported the only study that has assessed the role of these biomarkers in CD in a cross-sectional fashion [19].